According to a recent study conducted by BCC Research, the global market for In Vitro Diagnostics (IVD) Quality Controls is projected to experience a compound annual growth rate (CAGR) of 7.8% from 2024 to 2029. The study forecasts that the market, currently valued at $1.5 billion in 2024, will reach $2.1 billion by the end of 2029.
The demand for IVD quality controls is driven by their crucial role in ensuring the accuracy and reliability of diagnostic testing across laboratories, clinics, and hospitals worldwide. The comprehensive report by BCC Research examines the current landscape and future potential of these controls, focusing on competitive dynamics among industry players.
Key segments analyzed in the report include immunodiagnostics, clinical chemistry, hematology, hemostasis, molecular diagnostics, microbiology, and others. The market encompasses quality control products, data management solutions, and quality assurance services, with manufacturers categorized into third-party and OEM controls. The primary end users are hospitals, diagnostic laboratories, and academic institutions.
Geographically, the market spans North America, Europe, Asia-Pacific, and the Rest of the World, with detailed analyses of major countries within each region. The report provides insights into market shares and regulatory influences shaping the industry’s evolution, projecting market growth from 2023 as the base year, with forecasts extending to 2029.
The market for in vitro diagnostics quality controls is characterized by a variety of devices and products utilized in diagnostic testing. Daily quality control is essential, leading to continuous investment and innovation by numerous companies. To meet the stringent demands of accuracy and reliability, companies are committed to developing and updating their offerings, resulting in a dynamic market landscape where competitiveness is maintained through enhanced product portfolios.
Several factors contribute to the global market growth for in vitro diagnostics quality controls. The aging population and the increasing dependency on frequent diagnostic procedures drive the demand for IVD tests. Third-party quality control products are in high demand, as they offer accurate testing solutions that ensure unbiased assessments across various test systems. The rising incidence of chronic diseases and the strengthening of clinical laboratories further propel the usage of IVD quality controls. Additionally, the improvement of point-of-care testing (POCT) quality enhances the accuracy and reliability of rapid diagnosis and treatment decisions.
The report by BCC Research provides a comprehensive analysis of the global market for in vitro diagnostics quality controls, addressing key queries and profiling major market players such as BIOMERIEUX, DANAHER CORP., ABBOTT, BD, BIO-RAD LABORATORIES INC., MICROBIOLOGICS, BIO-TECHNE, F. HOFFMANN-LA ROCHE LTD., QUIDELORTHO CORP., SIEMENS HEATHNIEERS AG, SYSMEX CORP., and THERMO FISHER SCIENTIFIC INC.